000 01221 a2200361 4500
005 20250513062851.0
264 0 _c19940510
008 199405s 0 0 eng d
022 _a0362-5664
024 7 _a10.1097/00002826-199402000-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBonifati, V
245 0 0 _aBuspirone in levodopa-induced dyskinesias.
_h[electronic resource]
260 _bClinical neuropharmacology
_cFeb 1994
300 _a73-82 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBuspirone
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aDyskinesia, Drug-Induced
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xcomplications
700 1 _aFabrizio, E
700 1 _aCipriani, R
700 1 _aVanacore, N
700 1 _aMeco, G
773 0 _tClinical neuropharmacology
_gvol. 17
_gno. 1
_gp. 73-82
856 4 0 _uhttps://doi.org/10.1097/00002826-199402000-00008
_zAvailable from publisher's website
999 _c8148683
_d8148683